Suppr超能文献

激素避孕与女性性行为:欧洲性医学学会(ESSM)立场声明。

Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM).

机构信息

Outpatient Clinic of Psychosomatic Gynecology and Sexology, Leiden University Medical Centre, Leiden, the Netherlands.

Department of Psychiatry, Centre of Postgraduate Medical Education, Warsaw, Poland.

出版信息

J Sex Med. 2019 Nov;16(11):1681-1695. doi: 10.1016/j.jsxm.2019.08.005. Epub 2019 Sep 11.

Abstract

INTRODUCTION

Hormonal contraception is available worldwide in many different forms. Fear of side effects and health concerns are among the main reasons for not using contraceptives or discontinuing their use. Although the safety and efficacy of contraceptives have been extensively examined, little is known about their impact on female sexual function, and the evidence on the topic is controversial.

AIM

To review the available evidence about the effects of hormonal contraceptives on female sexuality in order to provide a position statement and clinical practice recommendations on behalf of the European Society of Sexual Medicine.

METHODS

A comprehensive review of the literature was performed.

MAIN OUTCOME MEASURE

Several aspects of female sexuality have been investigated, including desire, orgasmic function, lubrication and vulvovaginal symptoms, pelvic floor and urological symptoms, partner preference, and relationship and sexual satisfaction. For each topic, data were analyzed according to the different types of hormonal contraceptives (combined estrogen-progestin methods, progestin-only methods, and oral or non-oral options).

RESULTS

Recommendations according to the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence criteria and specific statements on this topic, summarizing the European Society of Sexual Medicine position, were developed.

CLINICAL IMPLICATIONS

There is not enough evidence to draw a clear algorithm for the management of hormonal contraception-induced sexual dysfunction, and further studies are warranted before conclusions can be drawn. A careful baseline psychological, sexual, and relational assessment is necessary for the health care provider to evaluate eventual effects of hormonal contraceptives at follow-up.

STRENGTHS & LIMITATIONS: All studies have been evaluated by a panel of experts who have provided recommendations for clinical practice.

CONCLUSION

The effects of hormonal contraceptives on sexual function have not been well studied and remain controversial. Available evidence indicates that a minority of women experience a change in sexual functioning with regard to general sexual response, desire, lubrication, orgasm, and relationship satisfaction. The pathophysiological mechanisms leading to reported sexual difficulties such as reduced desire and vulvovaginal atrophy remain unclear. Insufficient evidence is available on the correlation between hormonal contraceptives and pelvic floor function and urological symptoms. Both S, Lew-Starowicz M, Luria M, et al. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM). J Sex Med 2019;16:1681-1695.

摘要

简介

全世界有许多不同形式的激素避孕方法。担心副作用和健康问题是人们不使用或停止使用避孕方法的主要原因之一。尽管避孕药具的安全性和有效性已经得到了广泛的研究,但人们对其对女性性功能的影响知之甚少,而且关于这个主题的证据存在争议。

目的

回顾激素避孕药对女性性功能的影响的现有证据,以便代表欧洲性医学学会就这一问题提出立场声明和临床实践建议。

方法

对文献进行了全面的回顾。

主要观察指标

已研究了女性性功能的多个方面,包括欲望、性高潮功能、润滑和外阴阴道症状、盆底和泌尿科症状、伴侣偏好以及关系和性满意度。对于每个主题,根据不同类型的激素避孕药(雌孕激素联合方法、单纯孕激素方法、口服或非口服方法)的数据进行了分析。

结果

根据 2011 年牛津循证医学中心证据标准制定了建议,并就这一主题提出了具体声明,总结了欧洲性医学学会的立场。

临床意义

没有足够的证据来制定明确的管理激素避孕药引起的性功能障碍的算法,在得出结论之前,还需要进一步的研究。在后续随访中,医疗保健提供者需要对女性进行仔细的基线心理、性和关系评估,以评估激素避孕药的潜在影响。

优势与局限性

所有的研究都由一个专家组进行了评估,专家组为临床实践提供了建议。

结论

激素避孕药对性功能的影响尚未得到很好的研究,仍然存在争议。现有证据表明,少数女性在一般性反应、欲望、润滑、性高潮和关系满意度方面的性功能发生变化。导致报告的性困难(如欲望降低和外阴阴道萎缩)的病理生理机制尚不清楚。关于激素避孕药与盆底功能和泌尿科症状之间的相关性,证据不足。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验